Process-based Therapy for Difficult-to-treat Anxiety Disorders and Depression
PBTRAND
Process-based Therapy vs. Routine-CBT for Difficult-to-treat Anxiety Disorders and Depression
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim of this study is to test the relative efficacy of Process-based Therapy compared to traditional CBT delivered in routine practice (r-CBT) for difficult-to-treat anxiety disorders and depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2024
CompletedFirst Submitted
Initial submission to the registry
July 11, 2024
CompletedFirst Posted
Study publicly available on registry
July 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedJuly 30, 2024
July 1, 2024
11 months
July 11, 2024
July 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Depression Anxiety Stress Scale (DASS-21)
Emotional distress, minimum value=0, maximum value=63, higher scores mean worse outcome
Assessed at inclusion, at pre-treatment, at post-treatment (week 32) and at 6 month follow-up
Secondary Outcomes (9)
Euroqol-5D (EQ-5D)
Assessed at inclusion, at pre-treatment, at post-treatment (week 32) and at 6 month follow-up
Positive-Mental Health Scale (PMH)
Assessed at inclusion, at pre-treatment, at post-treatment (week 32) and at 6 month follow-up
Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS)
Assessed at inclusion, at pre-treatment, at post-treatment (week 32) and at 6 month follow-up
Depression Anxiety Stress Scale (DASS-10)
Assessed at inclusion, at pre-treatment, at post-treatment (week 32) and at 6 month follow-up
Acceptance and Action Questionnaire Version 2 (AAQ-2)
Assessed at inclusion, at pre-treatment, at post-treatment (week 32) and at 6 month follow-up
- +4 more secondary outcomes
Study Arms (2)
Process-based Cognitive Behavioral Therapy
EXPERIMENTALIn PBT (20 sessions), treatment is initiated by a collaborative interpretation of the dynamic network model using smartphone-based Ecological Momentary Assessment collected during the baseline. Based on the outcome of the dynamic network model, interventions are selected on the basis of empirical evidence for mechanisms of change matching to the central node of the individual patient, besides feedback loops and self-loops, as the key process maintaining the maladaptive pattern. Interventions are conceptualized in the evolutionary framework as variation, selection and retention of an adaptive mode of the central node related to the specific context of the problem. The change of this variable is monitored using daily judgements on the basis of EMA. Further treatment planning focuses on additional targets to establish the adaptive modes of the dimensions as defined in the positive network model. Concomitant medication is allowed and will be controlled in statistical analyses.
Traditional Cognitive Behavioral Therapy
ACTIVE COMPARATORIn r-CBT (20 sessions) a naturalistic setting is retained for treatment decisions. Treatment planning follows traditional theories about the effects of the interventions on factors maintaining the disorder, e.g. avoidance and exposure in anxiety disorder or reduced reinforcement of activities and behavioral activation in depression. Interventions are selected on the basis of common treatment manuals related to diagnoses, e.g. CBT for depression. Individual data from the behavioral analysis are used to taylor the techniques to the problem behaviors or dysfunctional thoughts of patients. Treatment process focuses mainly on the implementation of the manualized interventions adapted to the individual patient as recommended in the National guidelines for treatment of depression and anxiety disorders. Concomitant medication is allowed and will be controlled in statistical analyses.
Interventions
PBT (20 sessions), intervention planning based on the use of EMA data, feedback of dynamic network analysis and matching of interventions to central nodes of the network.
CBT (20 sessions), intervention planning as usual based on manual.
Eligibility Criteria
You may qualify if:
- A primary DSM-5 diagnosis of depressive or anxiety disorder
- At least two unsuccessful attempts of pharmacological or psychological treatment according to the German guidelines for the treatment of depression or anxiety disorders (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF)
- Age 18-65 years
- Sufficient knowledge of the German language
- Participating patients are not required to discontinue medication, but to keep medication constant over the treatment period
You may not qualify if:
- Increased suicidality
- Substance abuse or dependency
- Borderline personality disorder
- Pervasive developmental disorder
- Psychotic disorder
- Eating disorder
- Bipolar disorder
- Severe physical illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Goethe Universitylead
- Philipps University Marburgcollaborator
Study Sites (1)
JWGUniversity
Frankfurt am Main, Hesse, 60486, Germany
Related Publications (1)
Stangier U, Kohl V, Gorg N, Sendig L, Hufschmidt B, Bonarius D, Nemani A, Ebert M, Hofmann SG. Process-based therapy vs. routine-CBT for difficult-to-treat mood and anxiety disorders: study protocol for a randomized controlled trial. Trials. 2024 Dec 19;25(1):838. doi: 10.1186/s13063-024-08689-3.
PMID: 39702504DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Department of Clinical Psychology and Psychotherapy and Center for Psychotherapy
Study Record Dates
First Submitted
July 11, 2024
First Posted
July 24, 2024
Study Start
January 29, 2024
Primary Completion
December 31, 2024
Study Completion
July 30, 2025
Last Updated
July 30, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Beginning 3 months and ending 5 years following article publication. Data are available for 5 years at a third party website (Link to be included).
- Access Criteria
- Proposals should be directed to stangier@psych.uni-frankfurt.de. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in the main publication of outcomes, after deidentification (text, tables, figures, and appendices) will be shared. Further Study Protocol, Analysis Plan, Informed Consent Form and Analytic Code will be shared to researchers who provide a methodologically sound proposal.